Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Transplant rejection
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{short description|Rejection of transplanted tissue by the recipient's immune system}} {{Redirect|Host-versus-graft disease|the condition in which transplanted cells attack the recipient's cells|Graft-versus-host disease}} {{Infobox medical condition (new) | name = Transplant rejection | synonyms = | image = Lung transplant rejection - high mag.jpg | caption = [[Micrograph]] showing [[lung transplant]] rejection. Lung [[biopsy]]. [[H&E stain]]. | pronounce = | field = | symptoms = | complications = | onset = | duration = | types = | causes = | risks = | diagnosis = | differential = | prevention = | treatment =[[Immunosuppressive drugs]] | medication = | prognosis = | frequency = | deaths = |alt=|specialty=[[Immunology]]}} '''Transplant rejection''' occurs when [[Organ transplant|transplanted]] tissue is rejected by the recipient's [[immune system]], which destroys the transplanted tissue. Transplant rejection can be lessened by determining the molecular similitude between donor and recipient and by use of [[immunosuppressant drugs]] after transplant.<ref name="pmid11158412">{{cite journal | vauthors = Frohn C, Fricke L, Puchta JC, Kirchner H | title = The effect of HLA-C matching on acute renal transplant rejection | journal = Nephrology, Dialysis, Transplantation | volume = 16 | issue = 2 | pages = 355β360 | date = February 2001 | pmid = 11158412 | doi = 10.1093/ndt/16.2.355 | doi-access = free }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)